SynopsisVYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, The global Cytarabine and Daunorubicin Drugs market size is expected to reach US$ 184 million by 2029, growing at a CAGR of 5.3% from 2023 to 202.....
SynopsisVYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, The global Vyxeos market size is expected to reach US$ 184 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly dri.....
SynopsisAcute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia .....
SynopsisTrisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL). The global Trisenox market size is expected to reach US$ 75 million by 2029, growing .....
SynopsisArsenic trioxide is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL). The global Arsenic Trioxide Drugs market size is expected to reach US$ 75 mil.....
SynopsisVesanoid is medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream or ointment. For leukemia, it is taken by mouth for up to three months. The global Vesanoid market size is expected to .....
SynopsisTretinoin is medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream or ointment. For leukemia, it is taken by mouth for up to three months. The global Tretinoin Drugs market size is expe.....
SynopsisPegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegademase Bovine market size is expected to reach US$ 103.7 million by 2029, growing at a CAGR of 4.2%.....
SynopsisPegademase bovine Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Pegademase Bovine Drugs market size is expected to reach US$ 103.7 million by 2029, growing at a CAGR o.....
SynopsisAdagen Injection is a modified enzyme used for enzyme replacement therapy for the treatment of severe combined immunodeficiency. The global Adagen market size is expected to reach US$ 103.7 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. Th.....
